| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18829511 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 100 journal articles in the PubMed database | Email to a friend | | |
| Berenson JR, Yellin O, Boccia RV, et al.
Zoledronic Acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss. [Journal Article]
Clin Cancer Res 2008 Oct 1; 14(19):6289-95.
Abstract | Full Citation | Find Related Articles | | Gnant M, Mlineritsch B, Luschin-Ebengreuth G, et al.
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. [JOURNAL ARTICLE]
Lancet Oncol 2008 Aug 19.
Abstract | Full Citation | | Israeli RS, Rosenberg SJ, Saltzstein DR, et al.
The effect of zoledronic Acid on bone mineral density in patients undergoing androgen deprivation therapy. [Journal Article]
Clin Genitourin Cancer 2007 Mar; 5(4):271-7.
Abstract | Full Citation | Find Related Articles | | Polascik TJ, Given RW, Metzger C, et al.
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases. [Clinical Trial, Journal Article, Multicenter Study]
Urology 2005 Nov; 66(5):1054-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Välimäiki MJ, Farrerons-Minguella J, Halse J, et al.
Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: A multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial. [Journal Article]
Clin Ther 2007 Sep; 29(9):1937-49.
Abstract | Full Citation | | Ryan CW, Huo D, Demers LM, et al.
Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer. [Journal Article]
J Urol 2006 Sep; 176(3):972-8; discussion 978.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Black DM, Delmas PD, Eastell R, et al.
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
N Engl J Med 2007 May 3; 356(18):1809-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Brown JE, Ellis SP, Lester JE, et al.
Prolonged efficacy of a single dose of the bisphosphonate zoledronic Acid. [Journal Article]
Clin Cancer Res 2007 Sep 15; 13(18):5406-10.
Abstract | Full Citation | Find Related Articles | | Michaelson MD, Kaufman DS, Lee H, et al.
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
J Clin Oncol 2007 Mar 20; 25(9):1038-42.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
